TY  - BOOK
AU  - Mitra,Ashim K.
TI  - Ophthalmic drug delivery systems
T2  - Drugs and the pharmaceutical sciences
SN  - 0824741242
AV  - RE994 .O62 2003
U1  - 617.7061 22
PY  - 2003///
CY  - New York
PB  - Marcel Dekker
KW  - Ophthalmic drugs
KW  - Drug delivery systems
KW  - Eye diseases
KW  - drug therapy
KW  - Ophthalmic Solutions
KW  - administration & dosage
N1  - Includes bibliographical references and index; TOC; Fundamental considerations: overview of ocular drug delivery, Sreeraj Macha, Patrick M. Hughes, and Ashim K. Mitra; membrane transport processes in the eye, Gangadhar Sunkara and Uday Kompella; general considerations in ocular drug disposition, JamesE. Chastain. Transport models in ocular drug delivery: ocular drug transfer following systemic drug administration, Nelson L. Jumbe and Michael Miller; ocular pharmacokinetics and pharmacodynamics, Ronald Schoenwald; mathematical modelling of drugdistribution in the vitreous humour, Stuart Friederich, Bradley Saville, and Yu-Ling Cheng; anterior segment microdialysis, Kay Rittenhouse; posterior segment microdialysis, Sreeraj Macha and Ashim K. Mitra. Drug delivery systems: conventional systems;ocular penetration enhancers, Thomas Wai-Yip Lee and Joseph Robinson; corneal collagen shields for ocular delivery, Shiro Higaki, Marvin E. Myles, Jeanette M. Loutsch, and James M. Hill; the non-corneal route in ocular drug delivery, Imran Ahmed; oculariontophoresis, Marvin E. Myles, Jeanete M. Loutsch, Shiro Higaki, and James M. Hill; mucoadhesive polymers in ophthalmic drug delivery, Thomas Johnston, Clapton Dias, Hemant Alur and Ashim K. Mitra; microparticulates and nanoparticles in ocular drugdelivery, Murali K. Kothuri, Swathi Pinnamaneni, Nandita G. Das, and Sudip K. Das; dendrimers - an innovative and enhanced ocular drug delivery system, jeanette M. Loutsch, Desiree Ong, and James M. Hill; delivery of macromolecular therapeutic agents;ocular delivery and therapeutics of peptides and proteins, Surajit Dey, Ramesh Krishnamurthy, and Ashim K. Mitra; retinal disease models for development of drug and gene therapies, Leena Pitkanen, Lotta Salminen, and Arto Urtti; new experimentaltherapeutic approaches for degenerative diseases of the retina, Joyce Tombran-Tink; gene, oligonucleotide and ribozyme therapy in the eye, Sudip K. Das and Keith J. Miller. Regulatory aspects: regulatory considerations, Robert E. Roehrs and Scott D.Krueger; patent considerations, Robert E. Roehrs; Pharmacy
N2  - The second edition of this text assembles significant ophthalmic advances and encompasses breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery
UR  - http://www.loc.gov/catdir/enhancements/fy0647/2003277133-d.html
UR  - https://www.worldcat.org/title/ophthalmic-drug-delivery-systems/oclc/896776097&referer=brief_results
UR  - http://lib.ewubd.edu/ebook/8137
ER  -